Jump to content


Biomarker for Diffuse Scleroderma skin has been discovered!


Photo

Actelion’s Opsumit Approved by FDA for Pulmonary Arterial Hypertension.

PAH

  • Please log in to reply
No replies to this topic

#1 Joelf

Joelf

    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,610 posts
  • Location:West Sussex

Posted 22 October 2013 - 08:02 AM

Actelion’s Opsumit Approved by FDA for Pulmonary Arterial Hypertension.

 

The FDA has approved the use of Opsumit (Macitentan) for treatment of pulmonary arterial hypertension (PAH). The Guardian. 10/20/2013. (Also see: Opsumit/Macitentan)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.


Jo Frowde
ISN Assistant Webmaster

SD World Webmaster
ISN Sclero Forums Manager
ISN News Manager

ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)